JSE-listed Blue Label on Wednesday posted a decline in core headline earnings per share (HEPS) from 121.01c apiece in 2022 to 45.55c a share in the 2023 financial year. While consistent growth was seen in Blue Label’s core businesses in terms of revenue, gross profit and core HEPS for the year under review, 45%-owned Cell C continues to weigh on its financial performance.
